Filing Details

Accession Number:
0000950170-24-102517
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-08-30 21:00:03
Reporting Period:
2024-08-30
Accepted Time:
2024-08-30 21:00:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
899460 Mannkind Corp MNKD Pharmaceutical Preparations (2834) 133607736
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1589641 A Stuart Tross 1 Casper Street
Danbury CT 06810
Chief People & Workpl Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.01 Par Value Disposition 2024-08-30 45,000 $6.33 1,082,191 No 4 S Direct
Common Stock, $0.01 Par Value Disposition 2024-08-30 35,000 $6.32 1,047,191 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. Transaction occurred pursuant to Rule 10b5-1 Plan established May 31, 2024.
  2. The weighted average sales price for the transaction reported was $6.32 based on a range of prices between $6.25 and $6.38. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.